C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations
- PMID: 19532026
- DOI: 10.1097/MCP.0b013e3283218603
C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations
Abstract
Purpose of review: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations.
Recent findings: Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity.
Summary: Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.
Similar articles
-
Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.Curr Opin Pulm Med. 2010 Mar;16(2):112-7. doi: 10.1097/MCP.0b013e328335f039. Curr Opin Pulm Med. 2010. PMID: 20019614 Review.
-
Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2006 Oct 15;174(8):867-74. doi: 10.1164/rccm.200604-506OC. Epub 2006 Jun 23. Am J Respir Crit Care Med. 2006. PMID: 16799074
-
C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease.Respirology. 2008 Nov;13(7):1028-33. doi: 10.1111/j.1440-1843.2008.01403.x. Respirology. 2008. PMID: 18945322
-
C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.Med Princ Pract. 2008;17(3):202-8. doi: 10.1159/000117793. Epub 2008 Apr 10. Med Princ Pract. 2008. PMID: 18408388
-
Systemic inflammation and mortality in chronic obstructive pulmonary disease.Can J Physiol Pharmacol. 2007 Jan;85(1):141-7. doi: 10.1139/y06-093. Can J Physiol Pharmacol. 2007. PMID: 17487253 Review.
Cited by
-
Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.Inflammation. 2014 Apr;37(2):374-80. doi: 10.1007/s10753-013-9749-1. Inflammation. 2014. PMID: 24078279
-
Risk stratification in emergency patients by copeptin.BMC Med. 2014 May 16;12:80. doi: 10.1186/1741-7015-12-80. BMC Med. 2014. PMID: 24884642 Free PMC article.
-
Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2023 Jun 14;18:1219-1230. doi: 10.2147/COPD.S399671. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37337582 Free PMC article.
-
Monocyte distribution width (MDW) and DECAF: two simple tools to determine the prognosis of severe COPD exacerbation.Intern Emerg Med. 2024 Sep;19(6):1567-1575. doi: 10.1007/s11739-024-03632-5. Epub 2024 May 9. Intern Emerg Med. 2024. PMID: 38722501 Free PMC article.
-
Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14. Wien Klin Wochenschr. 2015. PMID: 25586444
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
